Diagnostic and prognostic potential of serum angiopoietin-2 expression in human breast cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 660-664

  Li, Ping ^a   He, Quanyong ^a   Luo, Chenqun ^a   Qian, Liyuan ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Angiopoietin 2; Breast cancer; Diagnosis; Prognosis

Indexed keywords

ANGIOPOIETIN 2; ANGPT2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; BLOOD; BREAST TUMOR; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANGIOPOIETIN-2; AREA UNDER CURVE; BIOMARKERS, TUMOR; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84923096914     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013, CA: a cancer journal for clinicians 2013; 63: 11-30.
2. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Sci 1997; 277: 55-60.
3. Conteduca V, Kopf B, Burgio SL, Bianchi E, Amadori D, De Giorgi U. The emerging role of anti-angiogenic therapy in ovarian cancer (Review). Int J Oncol 2014; 44: 1417-1424.
4. Katoh M. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review). Int J Mol Med 2013; 32: 763-767.
5. Eroglu Z, Stein CA, Pal SK. Targeting angiopoietin- 2 signaling in cancer therapy. Expert Opin Investig Drugs 2013; 22: 813-825
6. Thomas M, Augustin HG. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 2009; 12: 125-137.
7. Gerald D, Chintharlapalli S, Augustin HG, Benjamin LE. Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy. Cancer Res 2013; 73: 1649-1657
8. Hu B, Cheng SY. Angiopoietin-2: development of inhibitors for cancer therapy. Current Oncology Reports 2009; 11: 111-116.
9. Helfrich I, Edler L, Sucker A, Thomas M, Christian S, Schadendorf D, Augustin HG. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin Cancer Res 2009; 15: 1384-92.
10. Sfiligoi C, de Luca A, Cascone I, Sorbello V, Fuso L, Ponzone R, Biglia N, Audero E, Arisio R, Bussolino F, Sismondi P, De Bortoli M. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer. 2003; 103: 466-74.
11. Coelho AL, Araujo A, Gomes M, Catarino R, Marques A, Medeiros R. Circulating Ang-2 Mrna Expression Levels: Looking ahead to a New Prognostic Factor for NSCLC. PLoS One 2014; 9: e90009.
12. Chen HH, Weng BQ, Cheng KJ, Liu HY, Wang SQ, Lu YY. Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma grow- th. Vasc Cell 2014; 6: 4.
13. Li C, Fan J, Song X, Chen Y, Li C, Mi K, Ma H, Song Y, Tao X, Li G. Expression of angiopoietin- 2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma. PLoS One 2013; 8: e75388.
14. Pappa CA, Tsirakis G, Samiotakis P, Tsigaridaki M, Alegakis A, Goulidaki N, Alexandrakis MG. Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma. Cancer Invest 2013; 31: 385-389.
15. Li C, Sun CJ, Fan JC. Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma. Med Oncol 2013; 30: 571.
16. Diaz-Sanchez A, Matilla A, Nunez O. Serum angiopoietin- 2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma. Scand J Gastroenterol 2013; 48: 334-343.
17. Sallinen H, Heikura T, Laidinen S, Kosma VM, Heinonen S, Ylä-Herttuala S, Anttila M. Preo- perative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer. Int J Gynecol Cancer 2010; 20: 1498-1505.
18. Engin H, Ustundag Y, Tekin IO, Gökmen A, Ertop S, Ilikhan SU. Plasma concentrations of angiopoietin-1, angiopoietin-2 and Tie-2 in colon cancer. Eur Cytokine Netw 2012; 23: 68-71.
19. Fawzy A, Gaafar R, Kasem F, Ali SS, Elshafei M, Eldeib M. Importance of serum levels of angiopoietin- 2 and survivin biomarkers in non-small cell lung cancer. J Egypt Natl Canc Inst 2012; 24: 41-45.